L05 Antipsychotics Flashcards

1
Q

Describe briefly what ‘schizophrenia’ is.

A

Chronic disease that is highly disabling to social & vocational functioning

  • Onset in late adolescence / early adulthood
  • Lifetime incidence of schizophrenia = ~ 1%
  • Prevalence = ~0.3%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the five classical symptom domains of schizophrenia?

A

1) Positive symptoms
2) Negative symptoms
3) Cognitive symptoms
4) Aggressive symptoms
5) Anxiety / Depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain what the positive symptoms of schizophrenia are.

A

Abnormal behaviours are added & are often interspersed with periods during which negative symptoms predominate.

  • Usually the presentation of positive symptoms that is most disturbing to others leads to first referral for detection of schizophrenia
  • Patients usually lack insight on these +ve symptoms

E.g.:

  • Delusions (often paranoia)
  • Hallucinations (e.g. exhortatory voices)
  • Thought disorders (i.e. feeling that thoughts are controlled by an outside agency)
  • Stereotypical or aggressive behaviours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain what the negative symptoms of schizophrenia are.

A

Normal behaviours are subtracted & are often interspersed with periods during which positive symptoms predominate.

  • For the individual, the presentation of negative symptoms are often most distressing to themselves & are cognizant of (in contrast to lack of insight of +ve symptoms).
  • Generally become more dominant with disease progression
  • Frequently associated with depression consequently
  • Results in suicide in 10% of cases

E.g.:

  • Withdrawal from social contacts
  • Flattening of emotional responses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Patients who present with positive symptoms of schizophrenia are often aware of their display and are subsequently distressed about them. True or false?

A

False!
Pt w/ schizophrenia are generally aware & distressed by negative symptoms, BUT lack insight on positive symptoms displayed.
- Others are more disturbed by positive symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain what causes the manifestation of negative symptoms of schizophrenia.

A
Primary deficit of the illness (schizophrenia)
Secondary causes include:
- Depression
- Extrapyramidal symptoms (EPS)
- Environmental deprivation
- Positive symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain what the cognitive symptoms of schizophrenia are.

A

Cognitive dysfunction resulting in:

  • Impairment of selective attention
  • Impairment of working memory

Recently recognised to be a persistent core feature of disease, NOT iatrogenic
- Impt as it predicts level of social & vocational functioning & thus Tx outcome, rather than via positive symptoms (less prominent over time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cognitive symptoms of schizophrenia are manifested as a result of long-term use of antipsychotics. True or false?

A

False
Recently recognised to be a persistent core feature of schizophrenia, NOT via iatrogenic (i.e. by physician or medications) causes!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain the etiology of schizophrenia.

A

1) Genetic factors:
- Incomplete hereditary tendency, in which there is a 50% risk of being symptomatic for schizophrenia in monozygotic twin of affected individual
- Genetic studies established linkage to various chromosomal regions
- Genes for susceptibility have been elusive, but some candidate genes identified are e.g. DISC1, neuregulin, dysbindin 1, COMT
- Not all schizophrenics share the same mutations of susceptibility genes.

2) Environmental factors:
- Various theories relating to possible neurodevelopmental abnormalities e.g. maternal viral infections during pregnancy or obstetric complications

3) Neurodevelopmental disorder:
- Onset in late adulthood / early adulthood is consistent with neurodevelopment abnormality involving myelination of corticocortical pathways.
- Evidence of enlarged ventricles and abnormalities in laminar organisation of cortical cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What was the proposal of neurochemical theories primarily for in the pathophysiology of schizophrenia?

A

To account for the manifestation of positive symptoms of schizophrenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Briefly describe the neurochemical theories proposed to explain how the various symptoms of schizophrenia are manifested.

A

1) Dopamine theory:
- Amphetamine (dopaminergic compound) produce symptoms similar to acute schizophrenia
- Most important basis for pharmacotherapy: ALL antipsychotics are D2 receptor antagonists that correlate with clinical efficacy.

2) Serotonin theory:
- Lysergic acid diethylamide (LSD; 5-HT2 agonist) produces symptoms similar to acute schizophrenia
- Many newer atypical antipsychotics have 5-HT2 antagonism

3) Glutamate theory:
- Drugs that block NMDA receptor channels (e.g. phencyclidine, ketamine) produces symptoms similar to acute schizophrenia
- Gaining popularity in research, but yet to produce clinically useful drugs via NMDA agonist activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain what the dopamine pathways of the brain are.

A

1) Nigrostriatal pathway (D1 > D2&raquo_space; D3 = D4)
- From substantia nigra to dorsal striatum
- Involved in voluntary movement
- Antipsychotics may affect this pathway as off-target effects due to presence of D2 receptors, resulting in extrapyramidal symptoms (EPS)

2) Mesocortical pathway (primarily D4)
- From ventral tegmental area (VTA) to prefrontal cortex
- Involved in cognition & attention
- Dopamine is increased in acute schizophrenia

3) Mesolimbic pathways (primarily D4)
- From ventral tegmental area (VTA) to limbic brain
- Involved in reward & emotion
- Dopamine is increased in acute schizophrenia

4) Tuberinfundibular pathway (D3 > D2)
- From hypothalamus to anterior pituitary gland
- Regulates prolactin secretion into blood circulation
- Antipsychotics may affect this pathway as off-target effects due to presence of D2 receptors, resulting in gynaecomastia in males OR breast swelling, pain & lactation in females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain what ‘extrapyramidal side effects’ refer to.

A

Acute dystonias, tardive dyskinesia & akathisia
- i.e. motor symptoms

Extrapyramidal pathway involves the basal ganglia, including the dorsal striatum & substantial nigra

  • Thus, D2 antagonism of nigrostriatal pathway result in Parkinsonian-like syndrome.
  • However, pyramidal motor pathway is the output from primary motor cortex via pyramids of medulla oblongata to spinal cord.
  • Thus, motor side-effects are due to the actions on extrapyramidal motor pathways, rather on pyramidal motor pathway!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain what ‘acute dystonia’ refers to.

A

Parkinsonian-like syndrome:

  • Displayed as cogwheel rigidity & tremor at rest
  • Occur w/in first few weeks of Tx
  • Reversible when drug is stopped
  • Appeared to be caused by D2 antagonism of nigrostriatal pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain what ‘tardive dyskinesia’ refers to.

A

Tardive: Slow development over months / years of Tx
Dyskinesia: Repetitive & stereotypical involuntary movements of face, tongue & limbs

  • Occurs in 20-40% of patients on typical antipsychotics
  • Often irreversible
  • Most likely due to upregulation or hypersensitivity of dopamine receptors in the nigrostriatal pathway
  • Blockade of receptors in nigrostriatal dopaminergic pathway possibly led to upregulation of dopamine receptors -> tardive dyskinesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain what ‘akathisia’ refers to.

A

Involuntary movements & compulsion to act, in association with restlessness, anxiety & agitation.

  • Akathisia correlates directly w/ duration of medication.
  • Occurs in 20-40% of patients on typical antipsychotics
  • Often irreversible
  • Most likely due to upregulation of dopamine receptors in the nigrostriatal pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

There is a general positive correlation between the duration in which a patient is on typical antipsychotics with the development of tardive dyskinesia. True or false?

A

False.

Akathisia correlates directly with duration of antipsychotics, NOT tardive dyskinesia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Many schizophrenics are able to come off their antipsychotics & retain near pre-illness levels of function. True or false?

A

False

  • Schizophrenia is a chronic illness that requires patients to be on almost lifelong antipsychotics.
  • There is still an unmet need for improved antipsychotics!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
Name the classes of medications available for the treatment of schizophrenia.
Name some examples of each class of drugs.
A

1) Typical antipsychotics (-azine):
- In increasing order of D2 receptor affinity: Chlorpromazine, trifluoperazine, haloperidol, fluphenazine

2) Atypical antipsychotics:
- Serotonin-dopamine antagonism is the core of most atypical antipsychotics MOA
- E.g. [CORAA] Clozapine, olanzapine, risperidone, amisulpride & aripiprazole

20
Q

Both typical & atypical antipsychotics can control both positive & negative symptoms of schizophrenia. True or false?

A

False!
Typical antipsychotics can control ONLY positive symptoms of schizophrenia AND effects of atypical antipsychotics on negative symptoms, cognition & mood stability are weak!

21
Q

Which class of antipsychotics will result in stronger extrapyramidal side effects being experienced as potential side effects?

A

Typical antipsychotics

  • Due to less selectivity for D4 receptors
  • Result in off-target effects on nigrostriatal pathway by antagonising D2 receptors found on this pathway
22
Q

Which typical antipsychotic was the first drug used for the Tx of schizophrenia?

A

Chlorpromazine

- Derived from antihistamines like TCAs

23
Q

Which typical antipsychotic remains as one of the most widely used antipsychotic drugs for Tx of schizophrenia?

A

Haloperidol

24
Q

Which typical antipsychotic lacks M1 & H1 receptor antagonism activity?

A

Haloperidol

25
Q

What are some side effects experienced from the use of typical antipsychotics?

A

Chlorpromazine, trifluoperazine, haloperidol, fluphenazine:

  • Extrapyramidal SE: acute dystonias, tardive dyskinesia & akathisia
  • Antiadrenergic (alpha-1) SE: postural hypotension, dizziness

Chlorpromazine, trifluoperazine, fluphenazine:

(i. e. exclude haloperidol)
- Anticholinergic SE: blurred vision, dry mouth & constipation
- Antihistaminic SE: sedation, weight gain

26
Q

What makes an antipsychotic atypical?

A

Production of less extrapyramidal side effects.

Many atypical antipsychotics have:

  • Greater affinity for 5-HT2 receptor antagonism
  • Greater affinity for D4 receptor antagonism -> less EPS
  • Mixed antagonism at M1, H1, 5-HT2 & alpha-1 receptor
  • Thus, serotonin-dopamine antagonism forms the ‘core’ MOA for most atypical antipsychotics, BUT these properties do NOT define atypicality!!
27
Q

Which atypical antipsychotic is a selective D2/D3 antagonist?

A

Amisulpride

28
Q

Which atypical antipsychotic is a partial agonist that serves as a functional antagonist in the presence of dopamine?

A

Aripiprazole

  • Full 5-HT2 & 5-HT7 antagonism BUT partial agonist of D2 & D3
  • Has ONLY H1 & alpha-1 antagonism
  • NO M1 antagonism
29
Q

Which atypical antipsychotics are more effective against negative symptoms of severe schizophrenia?

A

Clozapine, olanzapine & risperidone

30
Q

Which atypical antipsychotics are more effective in ameliorating the cognitive dysfunction of severe schizophrenia, as compared to typical antipsychotics?

A

Clozapine & risperidone

- Due to additional 5-HT7 antagonism activities

31
Q

Which atypical antipsychotics are more effective at mood stabilisation of severe schizophrenia, as compared to typical antipsychotics?

A

Clozapine, olanzapine & risperidone

32
Q

What are some side effects experienced from the use of clozapine?

A

1) Extrapyramidal SE (less): acute dystonias, tardive dyskinesia & akathisia
2) Antiadrenergic (alpha-1) SE: postural hypotension, dizziness, reflex tachycardia
3) Anticholinergic SE (significant): blurred vision, dry mouth & constipation
4) Antihistaminic SE (significant): sedation

5) Clozapine-induced agranulocytosis (fatal: 1%)
- Regular blood counts are required to monitor pt
- Potentially fatal due to bone marrow supression
6) Drug-induced weight gain:
- Besides H1 antagonism, alpha-1 antagonism & 5-HT2 antagonism results in suppression of satiation -> hunger -> weight gain
7) Onset/exacerbation of diabetes:
- May not reverse even when drug is stopped
- Possible involvement of 5-HT antagonism in hypothalamus and/or pancreatic beta cells (unknown)

33
Q

Which particular fatal side effect led to the development of compounds related to clozapine w/o this adverse effect?

A

Clozapine-induced agranulocytosis

- Led to development of olanzapine

34
Q

What are some side effects experienced from the use of olanzapine?

A

1) Extrapyramidal SE (less): acute dystonias, tardive dyskinesia & akathisia
2) Antiadrenergic (alpha-1) SE: postural hypotension, dizziness, reflex tachycardia
3) Anticholinergic SE (significant): blurred vision, dry mouth & constipation
4) Antihistaminic SE (significant): sedation

5) Drug-induced weight gain:
- Besides H1 antagonism, alpha-1 antagonism & 5-HT2 antagonism results in suppression of satiation -> hunger -> weight gain
6) Onset/exacerbation of diabetes:
- May not reverse even when drug is stopped
- Possible involvement of 5-HT antagonism in hypothalamus and/or pancreatic beta cells (unknown)

35
Q

What condition is olanzapine experimentally used for currently?

A

Anorexia nervosa

36
Q

What are some side effects experienced from the use of risperidone?

A

1) Extrapyramidal SE (less): acute dystonias, tardive dyskinesia & akathisia
2) Antiadrenergic (alpha-1) SE (significant): postural hypotension, dizziness, reflex tachycardia
3) Anticholinergic SE: blurred vision, dry mouth & constipation
4) Antihistaminic SE: sedation

5) Drug-induced weight gain:
- Besides H1 antagonism, alpha-1 antagonism & 5-HT2 antagonism results in suppression of satiation -> hunger -> weight gain
6) Onset/exacerbation of diabetes:
- Higher chance with risperidone&raquo_space; olanzapine = clozapine
- May not reverse even when drug is stopped esp. risperidone
- Possible involvement of 5-HT antagonism in hypothalamus and/or pancreatic beta cells (unknown)

37
Q

Which atypical antipsychotics can result in significant dry mouth, blurred vision & constipation?

A

Clozapine & olanzapine

38
Q

Which atypical antipsychotics can result in significant sedation?

A

Clozapine & olanzapine

39
Q

Which atypical antipsychotic can result in significant reflex tachycardia & postural hypotension?

A

Risperidone

40
Q

Which atypical antipsychotics can result in a greater risk of the irreversibility of onset/exacerbation of diabetes?

A

Risperidone&raquo_space; clozapine & olanzapine

- Amisulpride may be an exception.

41
Q

Which atypical antipsychotic lack M1, H1, 5-Ht2 & alpha-1 receptor antagonism?

A

Amisulpride

42
Q

What are some side effects experienced from the use of amisulpride?

A

1) Extrapyramidal SE (less): acute dystonias, tardive dyskinesia & akathisia

2) Gynaecomastia in males / Breast swelling, pain & lactation in females:
- Increased prolactin secretion due to block of dopamine receptors in anterior pituitary glands along the tuberoinfundibular pathway.

43
Q

Which atypical antipsychotic has an atypical pattern of receptor affinities, as compared to the others within the class?

A

Amisulpride

44
Q

What are some side effects experienced from the use of aripiprazole?

A

1) Extrapyramidal SE (less): acute dystonias, tardive dyskinesia & akathisia
2) Antiadrenergic (alpha-1) SE (significant): postural hypotension, dizziness, reflex tachycardia
3) Antihistaminic SE: sedation

4) Drug-induced weight gain (possible):
- Besides H1 antagonism, alpha-1 antagonism & 5-HT2 antagonism results in suppression of satiation -> hunger -> weight gain
5) Onset/exacerbation of diabetes:
- May not reverse even when drug is stopped esp. risperidone
- Possible involvement of 5-HT antagonism in hypothalamus and/or pancreatic beta cells (unknown)

45
Q

What warning does FDA require to be placed on all atypical antipsychotics?

A

Risk of hyperglycaemia & onset/exacerbation of diabetes

46
Q

H1 & alpha-1 adrenoreceptor hypotheses do explain why chlorpromazine does not cause so much weight gain. True or false?

A

False!

47
Q

Why do atypical antipsychotics produce less extrapyramidal symptoms, as compared to typical antipsychotics?

A

1) Potent 5-HT2A receptor antagonism vs weaker D2 antagonism -> lower EPS and higher efficacy against negative symptoms (clozapine and olanzapine)
2) Higher D3 > D2 antagonism ratio favours actions on nucleus accumbens over striatum (mainly D1 and D2) (amisulpride)
3) Higher D4 > D2 antagonism ratio favours actions in prefrontal cortex over striatum (clozapine)
4) Higher D2 > D1 antagonism ratio blocks negative feedback of presynaptic D2 autoreceptor -> allows dopamine to continue being released i.e. less complete blockade of dopaminergic function conferred -> reduces the impact of antagonism in the striatum (amisulpride and risperidone)